By Assistant Professor Loretta Lau

Journal articles

Vetsch J; Wakefield CE; Duve E; McGill BC; Warby M; Tucker KM; Malkin D; Lau L; Ziegler DS, 2019, 'Parents', health care professionals', and scientists' experiences of a precision medicine pilot trial for patients with high-risk childhood cancer: A qualitative study', JCO Precision Oncology, 3, pp. 1 - 11, http://dx.doi.org/10.1200/PO.19.00235

Allanson BM; Weber MA; Jackett LA; Chan C; Lau L; Ziegler DS; Warby M; Mayoh C; Cowley MJ; Tucker KM; Long GV; Maher A; Anazodo A; Scolyer RA, 2018, 'Oral malignant gastrointestinal neuroectodermal tumour with junctional component mimicking mucosal melanoma', Pathology, 50, pp. 648 - 653, http://dx.doi.org/10.1016/j.pathol.2018.07.002

Ziegler DS; Wong M; Mayoh C; Kumar A; Tsoli M; Mould E; Tyrrell V; Khuong-Quang DA; Pinese M; Gayevskiy V; Cohn RJ; Lau LMS; Reynolds M; Cox MC; Gifford A; Rodriguez M; Cowley MJ; Ekert PG; Marshall GM; Haber M; Wong-Erasmus M, 2018, 'Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma', British Journal of Cancer, 119, pp. 693 - 696, http://dx.doi.org/10.1038/s41416-018-0251-2

Lee M; Teber ET; Holmes O; Nones K; Patch AM; Dagg RA; Lau LMS; Lee JH; Napier CE; Arthur JW; Grimmond SM; Hayward NK; Johansson PA; Mann GJ; Scolyer RA; Wilmott JS; Reddel RR; Pearson JV; Waddell N; Pickett HA, 2018, 'Telomere sequence content can be used to determine ALT activity in tumours', Nucleic Acids Research, 46, pp. 4903 - 4918, http://dx.doi.org/10.1093/nar/gky297

Dagg RA; Pickett HA; Neumann AA; Napier CE; Henson JD; Teber ET; Arthur JW; Reynolds CP; Murray J; Haber M; Sobinoff AP; Lau LMS; Reddel RR, 2017, 'Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres', Cell Reports, 19, pp. 2544 - 2556, http://dx.doi.org/10.1016/j.celrep.2017.05.087

Hayward NK; Wilmott JS; Waddell N; Johansson PA; Field MA; Nones K; Patch AM; Kakavand H; Alexandrov LB; Burke H; Jakrot V; Kazakoff S; Holmes O; Leonard C; Sabarinathan R; Mularoni L; Wood S; Xu Q; Waddell N; Tembe V; Pupo GM; De Paoli-Iseppi R; Vilain RE; Shang P; Lau LMS; Dagg RA; Schramm SJ; Pritchard A; Dutton-Regester K; Newell F; Fitzgerald A; Shang CA; Grimmond SM; Pickett HA; Yang JY; Stretch JR; Behren A; Kefford RF; Hersey P; Long GV; Cebon J; Shackleton M; Spillane AJ; Saw RPM; López-Bigas N; Pearson JV; Thompson JF; Scolyer RA; Mann GJ, 2017, 'Whole-genome landscapes of major melanoma subtypes', Nature, 545, pp. 175 - 180, http://dx.doi.org/10.1038/nature22071

Bradbury PM; Turner K; Mitchell C; Griffin KR; Middlemiss S; Lau L; Dagg R; Taran E; Cooper-White J; Fabry B; O'Neill GM, 2017, 'The focal adhesion targeting domain of p130Cas confers a mechanosensing function', Journal of Cell Science, 130, pp. 1263 - 1273, http://dx.doi.org/10.1242/jcs.192930

Scarpa A; Chang DK; Nones K; Corbo V; Patch AM; Bailey P; Lawlor RT; Johns AL; Miller DK; Mafficini A; Rusev B; Scardoni M; Antonello D; Barbi S; Sikora KO; Cingarlini S; Vicentini C; McKay S; Quinn MCJ; Bruxner TJC; Christ AN; Harliwong I; Idrisoglu S; McLean S; Nourse C; Nourbakhsh E; Wilson PJ; Anderson MJ; Fink JL; Newell F; Waddell N; Holmes O; Kazakoff SH; Leonard C; Wood S; Xu Q; Nagaraj SH; Amato E; Dalai I; Bersani S; Cataldo I; Dei Tos AP; Capelli P; Davì MV; Landoni L; Malpaga A; Miotto M; Whitehall VLJ; Leggett BA; Harris JL; Harris J; Jones MD; Humphris J; Chantrill LA; Chin V; Nagrial AM; Pajic M; Scarlett CJ; Pinho A; Rooman I; Toon C; Wu J; Pinese M; Cowley M; Barbour A; Mawson A; Humphrey ES; Colvin EK; Chou A; Lovell JA; Jamieson NB; Duthie F; Gingras MC; Fisher WE; Dagg RA; Lau LMS; Lee M; Pickett HA; Reddel RR; Samra JS; Kench JG; Merrett ND; Epari K; Nguyen NQ; Zeps N; Falconi M; Simbolo M; Butturini G; Van Buren G; Partelli S; Fassan M; Khanna KK; Gill AJ; Wheeler DA; Gibbs RA; Musgrove EA; Bassi C; Tortora G; Pederzoli P; Pearson JV, 2017, 'Whole-genome landscape of pancreatic neuroendocrine tumours', Nature, 543, pp. 65 - 71, http://dx.doi.org/10.1038/nature21063

Henson JD; Lau LM; Koch S; Martin La Rotta N; Dagg RA; Reddel RR, 2017, 'The C-Circle Assay for alternative-lengthening-of-telomeres activity', Methods, 114, pp. 74 - 84, http://dx.doi.org/10.1016/j.ymeth.2016.08.016

Scarpa A; Chang DK; Nones K; Corbo V; Patch A-M; Bailey P; Lawlor RT; Johns AL; Miller DK; Mafficini A; Rusev B; Scardoni M; Antonello D; Barbi S; Sikora KO; Cingarlini S; Vicentini C; McKay S; Quinn MCJ; Bruxner TJC; Christ AN; Harliwong I; Idrisoglu S; McLean S; Nourse C; Nourbakhsh E; Wilson PJ; Anderson MJ; Fink JL; Newell F; Waddell N; Holmes O; Kazakoff SH; Leonard C; Wood S; Xu Q; Hiriyur Nagaraj S; Amato E; Dalai I; Bersani S; Cataldo I; Dei Tos AP; Capelli P; Vittoria Davì M; Landoni L; Malpaga A; Miotto M; Whitehall VLJ; Leggett BA; Harris JL; Harris J; Jones MD; Humphris J; Chantrill LA; Chin V; Nagrial AM; Pajic M; Scarlett CJ; Pinho A; Rooman I; Toon C; Wu J; Pinese M; Cowley M; Barbour A; Mawson A; Humphrey ES; Colvin EK; Chou A; Lovell JA; Jamieson NB; Duthie F; Gingras M-C; Fisher WE; Dagg RA; Lau LMS; Lee M; Pickett HA; Reddel RR; Samra JS; Kench JG; Merrett ND; Epari K; Nguyen NQ; Zeps N; Falconi M; Simbolo M; Butturini G; Van Buren G; Partelli S; Fassan M; Khanna KK; Gill AJ; Wheeler DA; Gibbs RA; Musgrove EA; Bassi C; Tortora G; Pederzoli P; Pearson JV; Waddell N; Biankin AV; Grimmond SM, 2017, 'Correction: Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours', Nature, 550, pp. 548 - 548, http://dx.doi.org/10.1038/nature24026

Small AG; Thwe LM; Byrne JA; Lau L; Chan A; Craig ME; Cowell CT; Garnett SP, 2015, 'Neuroblastoma, body mass index, and survival: a retrospective analysis', Medicine United States, 94, http://dx.doi.org/10.1097/MD.0000000000000713

Saletta F; Seng M; Lau L, 2014, 'Advances in paediatric cancer treatment', Translational Pediatrics, 3, pp. 156 - 156, http://dx.doi.org/10.3978/j.issn.2224-4336.2014.02.01

Lee M; Hills M; Conomos D; Stutz MD; Dagg RA; Lau LMS; Reddel RR; Pickett HA, 2014, 'Telomere extension by telomerase and ALT generates variant repeats by mechanistically distinct processes', Nucleic Acids Research, 42, pp. 1733 - 1746, http://dx.doi.org/10.1093/nar/gkt1117

Farooqi AS; Dagg RA; Choi LMR; Shay JW; Reynolds CP; Lau LMS, 2014, 'Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations', Journal of Neuro Oncology, 119, pp. 17 - 26, http://dx.doi.org/10.1007/s11060-014-1456-8

Rafie S; Kim GY; Lau LM; Tang C; Brown C; Maderas NM, 2013, 'Assessment of Family Planning Services at Community Pharmacies in San Diego, California', Pharmacy, 1, pp. 153 - 159, http://dx.doi.org/10.3390/pharmacy1020153

Lau LMS; Dagg RA; Henson JD; Au AYM; Royds JA; Reddel RR, 2013, 'Detection of alternative lengthening of telomeres by telomere quantitative PCR', Nucleic Acids Research, 41, pp. e34 - e34, http://dx.doi.org/10.1093/nar/gks781

Bower K; Napier CE; Cole SL; Dagg RA; Lau LMS; Duncan EL; Moy EL; Reddel RR, 2012, 'Loss of Wild-Type ATRX Expression in Somatic Cell Hybrids Segregates with Activation of Alternative Lengthening of Telomeres', Plos One, 7, http://dx.doi.org/10.1371/journal.pone.0050062

Lau LMS; Wolter JK; Lau JTML; Cheng LS; Smith KM; Hansford LM; Zhang L; Baruchel S; Robinson F; Irwin MS, 2009, 'Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastoma', Oncogene, 28, pp. 2024 - 2033, http://dx.doi.org/10.1038/onc.2009.59

Lau LMS; Stuurman K; Weitzman S, 2008, 'Skeletal langerhans cell histiocytosis in children: Permanent consequences and health-related quality of life in long-term survivors', Pediatric Blood and Cancer, 50, pp. 607 - 612, http://dx.doi.org/10.1002/pbc.21322

Lau LMS; Nugent JK; Zhao X; Irwin MS, 2008, 'HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function', Oncogene, 27, pp. 997 - 1003, http://dx.doi.org/10.1038/sj.onc.1210707

Lau L; Hansford LM; Cheng LS; Hang M; Baruchel S; Kaplan DR; Irwin MS, 2007, 'Cyclooxygenase inhibitors modulate the p53/HDM2 pathway and enhance chemotherapy-induced apoptosis in neuroblastoma', Oncogene, 26, pp. 1920 - 1931, http://dx.doi.org/10.1038/sj.onc.1209981

Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S, 2006, 'Pulmonary Langerhans cell histiocytosis: A variable disease in childhood', Pediatric Blood and Cancer, 47, pp. 889 - 893, http://dx.doi.org/10.1002/pbc.20676

Lau L; Hargrave DR; Bartels U; Esquembre C; Bouffet E, 2006, 'Childhood brain tumour information on the Internet in the Chinese language', Child S Nervous System, 22, pp. 346 - 351, http://dx.doi.org/10.1007/s00381-005-1238-x

Lau L; Krafchik B; Trebo MM; Weitzman S, 2006, 'Cutaneous Langerhans cell histiocytosis in children under one year', Pediatric Blood and Cancer, 46, pp. 66 - 71, http://dx.doi.org/10.1002/pbc.20479

Lau L; Supko JG; Blaney S; Hershon L; Seibel N; Krailo M; Qu W; Malkin D; Jimeno J; Bernstein M; Baruchel S, 2005, 'A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study', Clinical Cancer Research, 11, pp. 672 - 677, http://dx.doi.org/10.1158/1078-0432.672.11.2

Lau L; Baruchel S, 2005, 'Can Canada sustain paediatric phase I trials? A national survey of cancer relapse in children', Canadian Journal of Clinical Pharmacology, 12, pp. e222 - e228

Shaw PJ; Bleakley M; Lau L, 2004, 'Unrelated cord blood transplant as salvage following non-engraftment of unrelated marrow transplant? [3]', Bone Marrow Transplantation, 34, pp. 275 - 276, http://dx.doi.org/10.1038/sj.bmt.1704557

Lau L; Tai D; Weitzman S; Grant R; Baruchel S; Malkin D, 2004, 'Factors Influencing Survival in Children with Recurrent Neuroblastoma', Journal of Pediatric Hematology Oncology, 26, pp. 227 - 232, http://dx.doi.org/10.1097/00043426-200404000-00003

Bartels U; Hargrave D; Lau L; Esquembre C; Humpl T; Bouffet E, 2003, 'Analysis of Paediatric Neuro-Oncological Information on the Internet in German Language', Klinische Padiatrie, 215, pp. 352 - 357, http://dx.doi.org/10.1055/s-2003-45491

Hargrave D; Bartels U; Lau L; Esquembre C; Bouffet E, 2003, 'Quality of childhood brain tumour information on the Internet in French language', Bulletin Du Cancer, 90, pp. 650 - 655

Lau L, 2002, 'Neuroblastoma: A single institution's experience with 128 children and an evaluation of clinical and biological prognostic factors', Pediatric Hematology and Oncology, 19, pp. 79 - 89, http://dx.doi.org/10.1080/08880010252825669

Conference Papers

Raiti L; Altekoester A; El-Kamand S; Tucker K; Warby M; Courtney E; Barahona P; Lau L; Trahair T; Marshall G; Ziegler D; Haber M; Tyrrell V; Pinese M; Quang DAK; Fuentes-Bolanos N, 2025, 'The Role of Germline Loss of Function CHEK2 Variants in the Development of Childhood-Onset Malignancies', in PEDIATRIC BLOOD & CANCER, WILEY, pp. S84 - S85

Tyrrell V; Mayoh C; Ekert P; Cowley M; Ziegler D; Wong M; Barahona P; Pinese M; Haber M; Salomon R; Courtney E; Lock R; Fuentes-Bolanos N; Marshall G; Warby M; Trahair T; Dong AKQ; Wakefield C; Tucker K; Barlow-Stewart K; Padhye B; Lau L, 2024, 'Zero Childhood Cancer National Precision Medicine Program: Improving outcomes for children with high risk cancer cancer utilising comprehensive, integrated multiomic profiling', in EUROPEAN JOURNAL OF HUMAN GENETICS, SPRINGERNATURE, GERMANY, Berlin, pp. 800 - 800, presented at 57th Conference of the European-Society-of-Human-Genetics (ESHG), GERMANY, Berlin, 01 June 2024 - 04 June 2024

Senapati A; Mateos M; Kate H; Ziegler D; Lau L; Wakefield C; Marshall G, 2023, 'FACTORS INFLUENCING UPTAKE OF INDIVIDUALISED PRECISION MEDICINE TREATMENT RECOMMENDATIONS FOR HIGH-RISK PAEDIATRIC ONCOLOGY PATIENTS: RESULTS FROM THE PRISM ENGAGEMENT WITH CLINICIANS (PRE-CLIN) STUDY', in PEDIATRIC BLOOD & CANCER, WILEY

Mateos M; Ajuyah P; Bolanos NF; Barahona P; Altekoester A; Wong-Erasmus M; Cui L; Pfaff E; Mackay A; Resnick A; Pinese M; Lau L; Quang DAK; Dias K; Goudie C; Mayoh C; Cowley M; El-Kamand S; Salkeld A; Rokita JL; Jones D; Juretic N; Vittorio O; Pfister S; Jabado N; Tsoli M; Holiday H; Mueller S; Guo Y; Waszak S; Perreault S; Jones C; Ziegler D, 2023, 'PEDIATRIC DIFFUSE MIDLINE GLIOMA PATIENTS HAVE A HIGH PREVALENCE OF TARGETABLE GERMLINE VARIANTS IN HOMOLOGOUS RECOMBINATION AND MISMATCH REPAIR GENES', in PEDIATRIC BLOOD & CANCER, WILEY, pp. S133 - S134

Xie J; Gifford A; Mao J; Cadiz R; Avila A; Yun DY; Zhou A; Dolman E; Fleuren E; Mayoh C; Barahona P; Lau L; Kamili A; Tsoli M; Marshall G; Ziegler D; Trahair T; Haber M; Tyrrell V; Lock R, 2022, 'Establishment and application of patient-derived xenograft models for personalised medicine in paediatric cancer', Sydney, presented at Children’s Cancer Institute - Research Symposium 2022, Sydney, 06 December 2022

Fordham A; Brown L; Mayoh C; Wong M; Barger Z; O'Regan L; Lim Kan Siam T; Xie J; Gunther K; Barahona P; Ajuyah P; Lau L; Ziegler D; Haber M; Tyrrell V; Lock R; Cowley M; Nicholls W; Daly R; Ekert P; Fleuren E, 2022, 'MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS', Vancouver, Canada, presented at Connective Tissue Oncology Society (CTOS) Annual Meeting 2022, Vancouver, Canada, 17 November 2022

Fleuren E; Dolman E; Lau L; Xie J; Batey D; Mayoh C; Barahona P; Sherstyuk A; Khuong Quang DA; Wong M; ZERO PDTT; ZERO OT; Thomas D; Mould E; Norris M; Haber M; Trahair T; Marshall G; Ziegler D; Tyrrell V; Cowley M; Lock R; Ekert P, 2020, 'Supporting clinical decision-making for PI3K/AKT/MTOR inhibitors for high-risk paediatric and AYA sarcoma', Virtual, presented at Connective Tissue Oncology Society (CTOS) Annual Meeting 2020, Virtual, 18 November 2020

Fleuren E; Dolman E; Lau L; Xie J; Batey D; Mayoh C; Barahona P; Khuong Quang DA; Wong M; ZERO PDTT; ZERO OT; Norris M; Haber M; Trahair T; Marshall G; Ziegler D; Tyrrell V; Cowley M; Lock R; Ekert P, 2020, 'Supporting clinical decision-making for PI3K/AKT/MTOR inhibitors for high-risk paediatric sarcoma patients', Virtual, presented at KCA Symposium 2020, Virtual, 17 September 2020

Haber M; Gamble L; Xiao L; Pandher R; Somers K; Murray J; Khan A; Yu D; Franshaw L; Burns MR; Tsoli M; Ehteda A; Cesare A; O’Connor A; Mussai F; de Santo C; Cheng P; Korotchkina L; Gurova K; Tyrrell V; Mould E; Lau L; Quang DAK; Mayoh C; Arndt G; Barahona P; Failes T; Fletcher J; Bolanos NF; Gauthier M-E; Gifford A; Grebert-Wade D; Kamili A; Kumar A; Nagabushan S; O’Brien T; Strong P; Sherstyuk A; Thomas D; Trahair T; Tucker K; Warby M; Wong M; Xie J; Evans K; Lock R; Chernova OB; Henderson M; Gudkov AV; Ekert P; Cowley MJ; Marshall GM; Ziegler DS; Norris MD, 2020, 'Abstract IA13: Molecular targeted therapies and precision medicine for children with neuroblastoma and other refractory malignancies', in Cancer Research, American Association for Cancer Research (AACR), pp. ia13 - ia13, http://dx.doi.org/10.1158/1538-7445.pedca19-ia13

Fleuren E; Lau L; Barahona P; Sherstyuk A; Mayoh C; Terry R; Khuong Quang DA; Wong M; Xie J; Batey D; Grebert-Wade D; Strong P; Lim JY; Chow S-O; Kumar A; Failes T; Arndt G; Mould E; Haber M; Norris M; Lock R; Trahair T; Marshall G; Ziegler D; Tyrrell V; Cowley M; Ekert P, 2020, 'Precision medicine for high-risk paediatric and AYA sarcomas', Lorne, presented at Lorne Cancer 2020, Lorne, 13 February 2020

Fleuren E; Xie J; Barahona P; Sherstyuk A; Batey D; Jin Yi L; Lau L; Khuong Quang DA; Failes T; Chow S-O; Mayoh C; Wong M; Kumar A; ZERO OT; ZERO PDTT; ZERO SMT; Thomas D; Trahair T; Haber M; Mould E; Lock R; Ziegler D; Tyrrell V; Cowley M; Ekert P, 2019, 'Personalised medicine for high-risk paediatric and AYA sarcoma patients', Tokyo, Japan, presented at Connective Tissue Oncology Society (CTOS) Annual Meeting, Tokyo, Japan, 13 November 2019, https://www.ctos.org/Portals/0/PDF/2019%20CTOS%20Final%20Program.pdf

Reddel R; Napier C; Bower K; Noble J; Huschtscha L; Dagg R; Lau L; Stutz M; Pickett H, 2013, 'GENETIC BASIS OF TELOMERE DISORDERS', in JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, AUSTRALIA, Univ Technol, Sydney, pp. 315 - 315, presented at 8th Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Univ Technol, Sydney, 08 May 2013 - 10 May 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325102500012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lau L; Stuurman K; Weitzman S, 2007, 'Skeletal Langerhans Cell Histiocytosis in children: Late effects and health-related quality of life in long-term survivors', in PEDIATRIC BLOOD & CANCER, WILEY-LISS, pp. 751 - 751, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000246239900032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lau LMS; Nugent JK; Irwin MS, 2007, 'Differential modulation of p73 isoforms by COX inhibitor in neuroblastoma', in PEDIATRIC BLOOD & CANCER, WILEY-LISS, pp. 601 - 601, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000246013900004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lau L; Stuurman K; Roposch A; Doda W; Weitzman S, 2004, 'Radiologically aggressive langerhans cell histiocytosis bone lesions (LCH) in children', in PEDIATRIC BLOOD & CANCER, WILEY-LISS, pp. 195 - 196, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000222479000028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stuurman KE; Lau L; Doda W; Weitzman S, 2004, 'The natural history and long-term complications of patients with bone Langerhans cell histiocytosis (LCH)', in PEDIATRIC BLOOD & CANCER, WILEY-LISS, pp. 204 - 204, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000222479000061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lau L; Shaw P, 2004, 'What is the significance of negative MIBG scan and urine catecholamines in children with neural crest tumors?', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, LA, New Orleans, pp. 812S - 812S, presented at 40th Annual Meeting of the American-Society-of-Clinical-Oncology, LA, New Orleans, 05 June 2004 - 08 June 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223512403223&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lau L; Sturrman K; Weitzman S, 2004, 'Evaluation of the risk of recurrence and diabetes insipidus in patients with langerhans cell histocytosis involving the skeletal system', in PEDIATRIC RESEARCH, INT PEDIATRIC RESEARCH FOUNDATION, INC, CA, San Francisco, pp. 301A - 301A, presented at Annual Meeting of the Pediatric-Academic-Societies, CA, San Francisco, 04 May 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000220591101778&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lau L; Malkin D, 2003, 'A retrospective analysis of factors contributing to survival in children with relapsed neuroblastoma', in PEDIATRIC RESEARCH, INT PEDIATRIC RESEARCH FOUNDATION, INC, WASHINGTON, SEATTLE, pp. 270A - 270A, presented at Annual Meeting of the Pediatric-Academic-Society, WASHINGTON, SEATTLE, 03 May 2003 - 06 May 2003, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000181897901543&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page